LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

Inicio・Lista de Acciones・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Cerrado

SectorSalud

36.01 0.53

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

35.87

Máximo

36.16

Métricas clave
By Trading Economics
Ingresos	11M 51M
Ventas	39M 239M
P/B Media del Sector	11.697 121.746
BPA	1.08
Margen de beneficio	21.242
Empleados	268
EBITDA	14M 73M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+31.21% upside

Dividendos
By Dow Jones
Próximas Ganancias	24 feb 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	448M 2.1B
Apertura anterior	35.48
Cierre anterior	36.01

Noticias sobre sentimiento de mercado

By Acuity

34%

66%

94 / 351 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

29.8 / N/A Soporte y Resistencia

Harmony Biosciences Holdings Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

16 feb 2026, 22:17 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP 1st Half Net Profit, Dividend Rise; Signs $4.3 Billion Silver Streaming Deal

16 feb 2026, 23:48 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

16 feb 2026, 23:48 UTC

Charlas de Mercado

Nikkei May Decline; Prime Minister Takaichi's Policy Steps in Focus -- Market Talk

16 feb 2026, 23:23 UTC

Adquisiciones, fusiones, absorciones

BHP Shares Up 7.0% After Silver Streaming Deal, Profit Beat

16 feb 2026, 23:20 UTC

Adquisiciones, fusiones, absorciones

BHP Exploring Other Infrastructure Deals as It Chases $10 Billion Target - Interview

16 feb 2026, 22:48 UTC

Adquisiciones, fusiones, absorciones

BHP CFO: Brokers Value BHP's Total Stake in Antamina Around $4.5 Billion

16 feb 2026, 22:48 UTC

Adquisiciones, fusiones, absorciones

BHP CFO: Has Desalination, Other Power Assets on Which Deals Could Be Considered

16 feb 2026, 22:48 UTC

Adquisiciones, fusiones, absorciones

BHP CFO: Wants to Make Sure It Does Not Give Up Any Strategic, Operational Control of Assets

16 feb 2026, 22:48 UTC

Adquisiciones, fusiones, absorciones

BHP CFO: Will Allocate Cash From Asset Deals to Growth, Shareholder Returns

16 feb 2026, 22:47 UTC

Adquisiciones, fusiones, absorciones

BHP CFO: Won't Put Deadline on $10 Billion Cash Unlock Target

16 feb 2026, 22:47 UTC

Adquisiciones, fusiones, absorciones

BHP CFO: Bar Very High For Asset Deals

16 feb 2026, 22:47 UTC

Adquisiciones, fusiones, absorciones

BHP CFO: Sees 'Quite a Lot of Opportunities' in Potential Infrastructure Deals

16 feb 2026, 22:35 UTC

Charlas de Mercado

Australian Jobs Data Could Confirm Market Too Tight -- Market Talk

16 feb 2026, 22:02 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP 1H Net Profit, Dividend Rise; Signs $4.3 Billion Silver Streaming Deal

16 feb 2026, 21:48 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP: Optimistic That Economic Backdrop Supportive For Key Commodities

16 feb 2026, 21:48 UTC

Adquisiciones, fusiones, absorciones

Wheaton Precious Metals: Acquisition Immediately Increases Production and Cash Flow Profile

16 feb 2026, 21:48 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP: China's Economy Resilient; India Continues to Outperform

16 feb 2026, 21:47 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP: Streaming, WAIO Power Deals Unlock Over $6 Billion of Cash Combined

16 feb 2026, 21:47 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP: Sees Potential to Unlock Up to $10 Billion From Portfolio, Asset Management

16 feb 2026, 21:47 UTC

Adquisiciones, fusiones, absorciones

Wheaton Precious Metals to Have Combined 67.5% of All the Silver Produced From Antamina, Up From 33.75% Currently

16 feb 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

Wheaton Precious Metals: Upfront Payment to Be Funded Through Combination of Existing Liquidity and New Financing

16 feb 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

Wheaton Precious Metals Will Pay BHP Total Upfront Cash Consideration of $4.3B on Closing

16 feb 2026, 21:46 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP Interim Dividend Represents 60% Payout Ratio

16 feb 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

Wheaton Precious Metals in Definitive Precious Metals Purchase Agreement BHP Subsidiary for Its 33.75% Portion of Silver Produced at Antamina Mine in Peru

16 feb 2026, 21:45 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP: Copper Contributed 51% of 1H Underlying Ebitda

16 feb 2026, 21:43 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP Net Debt $14.69 Billion at Dec. 31, Up 25% On-Year

16 feb 2026, 21:43 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP 1H Net Operating Cash Flow $9.37 Billion, Up 13% On-Year

16 feb 2026, 21:42 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP 1H Underlying Ebitda $15.46 Billion, Up 25% On-Year

16 feb 2026, 21:42 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP Was Expected to Record Underlying Profit of $6.03 Billion According to Visible Alpha

16 feb 2026, 21:41 UTC

Ganancias

Adquisiciones, fusiones, absorciones

BHP 1H Underlying Profit $6.20 Billion, Up 22% On-Year

Comparación entre iguales

Cambio de precio

Harmony Biosciences Holdings Inc Esperado

Precio Objetivo

By TipRanks

31.21% repunte

Estimación a 12 meses

Media 47.25 USD 31.21%

Máximo 55 USD

Mínimo 42 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

29.8 / N/ASoporte y Resistencia

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentimiento

By Acuity

94 / 351 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.